BCN Peptides reforça el compromís amb la sostenibilitat mediambiental amb l’actualització de la nostra flota a vehicles 100% elèctrics reduint emissions i contribuint a un futur més net, eficient i responsable.
Aquest projecte ha estat possible gràcies al finançament públic del Programa MOVES III, referència exp. ICA023/21/028368, ICA023/21/006698, ICA023/21/034612 i ICA023/21/021137 atorgats en virtut de la Resolució ACC/2914/2021, de 27 de setembre, dins la convocatòria de 2021 per a les subvencions del Programa d’incentius a la mobilitat eficient i sostenible (MOVES III). Per a un planeta més verd i saludable!
BCN Peptides reinforces its commitment to environmental sustainability by updating our fleet to 100% electric vehicles, reducing emissions and contributing to a cleaner, more efficient, and responsible future.
This project was made possible thanks to public funding from the MOVES III Program, reference exp. ICA023/21/028368, ICA023/21/006698, ICA023/21/034612 and ICA023/21/021137 granted under Resolution ACC/2914/2021, of September 27, within the 2021 call for subsidies from the Program of incentives for efficient and sustainable mobility (MOVES III).For a greener and healthier planet!
BCN Peptides refuerza su compromiso con la sostenibilidad medioambiental con la actualización de nuestra flota a vehículos 100% eléctricos, reduciendo emisiones y contribuyendo a un futuro más limpio, eficiente y responsable.
Este proyecto ha sido posible gracias a la financiación pública del Programa MOVES III, referencia exp. ICA023/21/028368, ICA023/21/006698, ICA023/21/034612 y ICA023/21/021137 otorgadas en virtud de la Resolución ACC/2914/2021, de 27 de septiembre, dentro de la convocatoria de 2021 para las subvenciones del Programa de incentivos a la movilidad eficiente y sostenible (MOVES III). ¡Por un planeta más verde y saludable!
🎉BCN Peptides at the XIX Iberian Peptide Meeting (EPI 2025) in Santiago de Compostela!
We are excited to announce that our Sales Area Manager Oriol Esquivias, PhD will be attending the XIX Iberian Peptide Meeting (EPI 2025) in Santiago de Compostela! This event is a fantastic opportunity to explore the latest advancements shaping the future of peptides.
At BCN Peptides, we are committed to staying at the forefront of peptide innovation. Attending EPI 2025 allows us to engage in meaningful discussions, gain insights from cutting-edge presentations, and strengthen our presence in the market.
As a leading Spanish peptide manufacturer, we are proud to participate and support scientific events that foster research and development within our territory. We look forward to connecting with industry leaders, researchers, and collaborators to discuss how BCN Peptides can contribute to advancing research in peptides.
📅 Dates: February 26–28, 2025
📍 Location: Hospedería San Martín Pinario, Santiago de Compostela, Spain
🔗 Contact us at info@bcnpeptides.com or +34 93 819 13 99
Looking forward to seeing you at EPI 2025!
🗽New York, here we come! Join us for DCAT Week, March 17-20.
BCN Peptides is attending DCAT (Drug, Chemical & Associated Technologies Association), a key event for engaging with industry leaders and discussing innovative peptide solutions.
⏳🤝Countdown is on! Schedule a meeting with Stephanie Wang or Dr. Jordi Piró and let’s connect in NYC!
🚀 Less than 2 weeks to go for BIO-Europe Spring (March 17-19, 2025)!
Time to lock in your meetings! 🗓️ Connect with Helena Sabata Perez and dive into the cutting-edge of peptide innovation.
➡️ https://lnkd.in/ejpKFQWF
See you in Milan!